These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
285 related articles for article (PubMed ID: 20195621)
1. Expression of Lgr5 in human colorectal carcinogenesis and its potential correlation with beta-catenin. Fan XS; Wu HY; Yu HP; Zhou Q; Zhang YF; Huang Q Int J Colorectal Dis; 2010 May; 25(5):583-90. PubMed ID: 20195621 [TBL] [Abstract][Full Text] [Related]
2. Expression of Lgr5, a marker of intestinal stem cells, in colorectal cancer and its clinicopathological significance. He S; Zhou H; Zhu X; Hu S; Fei M; Wan D; Gu W; Yang X; Shi D; Zhou J; Zhou J; Zhu Z; Wang L; Li D; Zhang Y Biomed Pharmacother; 2014 Jun; 68(5):507-13. PubMed ID: 24751002 [TBL] [Abstract][Full Text] [Related]
3. TRIB3 Interacts With β-Catenin and TCF4 to Increase Stem Cell Features of Colorectal Cancer Stem Cells and Tumorigenesis. Hua F; Shang S; Yang YW; Zhang HZ; Xu TL; Yu JJ; Zhou DD; Cui B; Li K; Lv XX; Zhang XW; Liu SS; Yu JM; Wang F; Zhang C; Huang B; Hu ZW Gastroenterology; 2019 Feb; 156(3):708-721.e15. PubMed ID: 30365932 [TBL] [Abstract][Full Text] [Related]
4. CBB1003, a lysine-specific demethylase 1 inhibitor, suppresses colorectal cancer cells growth through down-regulation of leucine-rich repeat-containing G-protein-coupled receptor 5 expression. Hsu HC; Liu YS; Tseng KC; Yang TS; Yeh CY; You JF; Hung HY; Chen SJ; Chen HC J Cancer Res Clin Oncol; 2015 Jan; 141(1):11-21. PubMed ID: 25060070 [TBL] [Abstract][Full Text] [Related]
5. LGR5 promotes survival in human colorectal adenoma cells and is upregulated by PGE2: implications for targeting adenoma stem cells with NSAIDs. Al-Kharusi MR; Smartt HJ; Greenhough A; Collard TJ; Emery ED; Williams AC; Paraskeva C Carcinogenesis; 2013 May; 34(5):1150-7. PubMed ID: 23349017 [TBL] [Abstract][Full Text] [Related]
6. LGR5 regulates survival through mitochondria-mediated apoptosis and by targeting the Wnt/β-catenin signaling pathway in colorectal cancer cells. Hsu HC; Liu YS; Tseng KC; Tan BC; Chen SJ; Chen HC Cell Signal; 2014 Nov; 26(11):2333-42. PubMed ID: 25025569 [TBL] [Abstract][Full Text] [Related]
7. The Expression of Stem Cell Marker LGR5 and Its Coexpression with Β-Catenin in Sporadic Colorectal Carcinoma and Adenoma: A Comparative Immunohistochemical Study. Ahmed EM; Farag AS; Abdelwahed MS; Hanbazazh M; Samman A; Ashmawy D; Abd-Elhameed NR; Tharwat M; Othman AE; Shawky TA; Attia RM; Ibrahim AA; Azzam S; Elhussiny MEA; Nasr M; Naeem SA; Abd-Elhay WM; Ali Alfaifi AM; Hasan A Medicina (Kaunas); 2023 Jun; 59(7):. PubMed ID: 37512045 [No Abstract] [Full Text] [Related]
8. SPDEF Induces Quiescence of Colorectal Cancer Cells by Changing the Transcriptional Targets of β-catenin. Lo YH; Noah TK; Chen MS; Zou W; Borras E; Vilar E; Shroyer NF Gastroenterology; 2017 Jul; 153(1):205-218.e8. PubMed ID: 28390865 [TBL] [Abstract][Full Text] [Related]
9. NHE8 Deficiency Promotes Colitis-Associated Cancer in Mice via Expansion of Lgr5-Expressing Cells. Xu H; Li J; Chen H; Ghishan FK Cell Mol Gastroenterol Hepatol; 2019; 7(1):19-31. PubMed ID: 30465020 [TBL] [Abstract][Full Text] [Related]
10. [Expression of CD10 in cancer-associated fibroblasts and its effect on initiation and progression of colorectal carcinoma]. Zhu Y; Zheng JJ; Yang F; Nie QQ; Zhu ZL; Deng H Zhonghua Bing Li Xue Za Zhi; 2016 Dec; 45(12):859-865. PubMed ID: 28056302 [No Abstract] [Full Text] [Related]
11. Characterization of LGR5 stem cells in colorectal adenomas and carcinomas. Baker AM; Graham TA; Elia G; Wright NA; Rodriguez-Justo M Sci Rep; 2015 Mar; 5():8654. PubMed ID: 25728748 [TBL] [Abstract][Full Text] [Related]
12. Most colitis associated carcinomas lack expression of LGR5: a preliminary study with implications for unique pathways of carcinogenesis compared to sporadic colorectal carcinoma. Iwaya M; Ota H; Nakajima T; Uehara T; Riddell R; Conner J BMC Cancer; 2021 Feb; 21(1):119. PubMed ID: 33541282 [TBL] [Abstract][Full Text] [Related]
13. Characterization of LGR5 expression in poorly differentiated colorectal carcinoma with mismatch repair protein deficiency. Nakajima T; Uehara T; Iwaya M; Kobayashi Y; Maruyama Y; Ota H BMC Cancer; 2020 Apr; 20(1):319. PubMed ID: 32293346 [TBL] [Abstract][Full Text] [Related]
14. Significance of Lgr5(+ve) cancer stem cells in the colon and rectum. Takahashi H; Ishii H; Nishida N; Takemasa I; Mizushima T; Ikeda M; Yokobori T; Mimori K; Yamamoto H; Sekimoto M; Doki Y; Mori M Ann Surg Oncol; 2011 Apr; 18(4):1166-74. PubMed ID: 21125339 [TBL] [Abstract][Full Text] [Related]
16. [Expression of Wnt5a, APC, β-catenin and their clinical significance in human colorectal adenocarcinoma]. Cao YC; Yang F; Liu XH; Xin X; Wang CC; Geng M Zhonghua Zhong Liu Za Zhi; 2012 Sep; 34(9):674-8. PubMed ID: 23159080 [TBL] [Abstract][Full Text] [Related]
17. A randomized clinical trial of the effects of supplemental calcium and vitamin D3 on the APC/β-catenin pathway in the normal mucosa of colorectal adenoma patients. Ahearn TU; Shaukat A; Flanders WD; Rutherford RE; Bostick RM Cancer Prev Res (Phila); 2012 Oct; 5(10):1247-56. PubMed ID: 22964475 [TBL] [Abstract][Full Text] [Related]
18. Lgr5 over-expression is positively related to the tumor progression and HER2 expression in stage pTNM IV colorectal cancer. Gao FJ; Chen JY; Wu HY; Shi J; Chen M; Fan XS; Huang Q Int J Clin Exp Pathol; 2014; 7(4):1572-9. PubMed ID: 24817953 [TBL] [Abstract][Full Text] [Related]
19. [The significance of beta-catenin and matrix metalloproteinase-7 expression in colorectal adenoma and carcinoma]. Duan GJ; Yan XC; Bian XW; Li J; Chen X Zhonghua Bing Li Xue Za Zhi; 2004 Dec; 33(6):518-22. PubMed ID: 15634446 [TBL] [Abstract][Full Text] [Related]
20. The role of tumor budding in colorectal adenocarcinoma: Possible involvement of the intestinal cancer stem cell marker Lgr5. Sadek SA; A Rehim DM; Fatima S Indian J Pathol Microbiol; 2020; 63(1):32-37. PubMed ID: 32031119 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]